Base de dados : LILACS
Pesquisa : D12.776.260.725 [Categoria DeCS]
Referências encontradas : 4 [refinar]
Mostrando: 1 .. 4   no formato [Detalhado]

página 1 de 1

  1 / 4 LILACS  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Chile
Texto completo
Id: biblio-1011429
Autor: Li, Meng; Zhang, Hailan; Liu, Huiying; Tian, Hongzhong; Tang, Xiaobing; Bai, Yuzuo; Wang, Weilin.
Título: Abnormal expression of TBX4 during anorectal development in rat embryos with ethylenethiourea-induced anorectal malformations
Fonte: Biol. Res;52:27, 2019. tab, graf.
Idioma: en.
Projeto: National Natural Science Foundation of China.
Resumo: BACKGROUND: To assess the expression of T-box transcription factor 4 (TBX4) during the anorectal development in normal and ethylenethiourea (ETU)-induced anorectal malformations (ARM) rat embryos. METHODS: Anorectal malformations was induced by ETU on the 10th gestational day (E10) in rat embryos. Spatiotemporal expression of TBX4 was evaluated in normal (n = 490) and ETU-induced ARM rat embryos (n = 455) from E13 to E16 by immunohistochemical staining, Western blot analysis and real-time RT-PCR. RESULTS: In the normal embryos, immunohistochemical staining revealed that TBX4 expression was detected in the epithelium of hindgut and urorectal septum (URS) on E13. TBX4-immunopositive cells were increased significantly in the epithelium of hindgut and URS, the future anal orifice part of cloacal membrane on E14. On E15, abundant stained cells were observed in the rectum, URS and dorsal cloacal membrane and the expression of positive cells reached its peak. On E16, only sporadic positive cells were distributed in the epithelium of the distal rectum. In the ARM embryos, the hindgut/rectum, URS and dorsal cloacal membrane were faint for TBX4 immunohistochemical staining. In the normal group, TBX4 protein and mRNA expression showed time-dependent changes in the hindgut/rectum from E13 to E16 on Western blot and real-time RT-PCR. On E13 and E15, the expression level of TBX4 mRNA in the ARM group was significantly lower than that in the normal group (P < 0.05). On E15, the expression level of TBX4 protein in the ARM group was significantly lower than that in the normal group (P < 0.05). CONCLUSIONS: The expression of TBX4 was downregulated in ETU-induced ARM embryos, which may play important roles in the pathogenesis of anorectal development.
Descritores: Regulação da Expressão Gênica/genética
Proteínas com Domínio T/genética
Etilenotioureia/farmacologia
Malformações Anorretais/genética
-Imuno-Histoquímica
Western Blotting
Ratos Wistar
Proteínas com Domínio T/metabolismo
Reação em Cadeia da Polimerase em Tempo Real
Malformações Anorretais/induzido quimicamente
Limites: Animais
Feminino
Gravidez
Ratos
Responsável: CL1.1 - Biblioteca Central


  2 / 4 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: biblio-1040227
Autor: Shu, Xuan; Dong, Zejun; Cheng, Liuhanghang; Shu, Shenyou.
Título: DNA hypermethylation of Fgf16 and Tbx22 associated with cleft palate during palatal fusion
Fonte: J. appl. oral sci;27:e20180649, 2019. graf.
Idioma: en.
Projeto: National Science Foundation of China; . Natural Science Foundation of Guangdong Province.
Resumo: Abstract Objective: Cleft palate (CP) is a congenital birth defect caused by the failure of palatal fusion. Little is known about the potential role of DNA methylation in the pathogenesis of CP. This study aimed to explore the potential role of DNA methylation in the mechanism of CP. Methodology: We established an all-trans retinoic acid (ATRA)-induced CP model in C57BL/6J mice and used methylation-dependent restriction enzymes (MethylRAD, FspEI) combined with high-throughput sequencing (HiSeq X Ten) to compare genome-wide DNA methylation profiles of embryonic mouse palatal tissues, between embryos from ATRA-treated vs. untreated mice, at embryonic gestation day 14.5 (E14.5) (n=3 per group). To confirm differentially methylated levels of susceptible genes, real-time quantitative PCR (qPCR) was used to correlate expression of differentially methylated genes related to CP. Results: We identified 196 differentially methylated genes, including 17,298 differentially methylated CCGG sites between ATRA-treated vs. untreated embryonic mouse palatal tissues (P<0.05, log2FC>1). The CP-related genes Fgf16 (P=0.008, log2FC=1.13) and Tbx22 (P=0.011, log2FC=1.64,) were hypermethylated. Analysis of Fgf16 and Tbx22, using Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG), identified 3 GO terms and 1 KEGG pathway functionally related to palatal fusion. The qPCR showed that changes in expression level negatively correlated with methylation levels. Conclusions: Taken together, these results suggest that hypermethylation of Fgf16 and Tbx22 is associated with decreased gene expression, which might be responsible for developmental failure of palatal fusion, eventually resulting in the formation of CP.
Descritores: Fissura Palatina/genética
Metilação de DNA
Proteínas com Domínio T/genética
Fatores de Crescimento de Fibroblastos/genética
-Valores de Referência
Expressão Gênica
Fissura Palatina/embriologia
Fissura Palatina/patologia
Análise de Sequência de DNA
Proteínas com Domínio T/análise
Domínios e Motivos de Interação entre Proteínas
Reação em Cadeia da Polimerase em Tempo Real
Fatores de Crescimento de Fibroblastos/análise
Camundongos Endogâmicos C57BL
Limites: Animais
Masculino
Feminino
Responsável: BR28.1 - Serviço de Biblioteca e Documentação Professor Doutor Antônio Gabriel Atta


  3 / 4 LILACS  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
Id: lil-689563
Autor: Sánchez, Dulfary; Lefebvre, Céline; García, Luis F; Barrera, Luis F.
Título: Variants in the IFN ? transcription factor genes TBET, STAT1, STAT4, and HLX and the risk of pulmonary tuberculosis in a Colombian population: a case-control study / Variantes en los factores de transcripción para IFN ?, TBET, STAT1 , STAT4 y HLX , y el riesgo de desarrollar tuberculosis pulmonar en un estudio de casos y controles de una población colombiana
Fonte: Biomédica (Bogotá);33(2):259-267, abr.-jun. 2013. tab.
Idioma: es.
Resumo: Introduction: Interferon gamma (IFN ? ) is the most potent cytokine involved in the control of Mycobacterium tuberculosis ( Mtb ), the etiological agent of human tuberculosis (TB). Patients with active TB present reduced levels of IFN ? , which may explain the lack of effective immunity against Mtb in these patients. The diminished expression of or functional alterations in trans-acting factors that regulate IFN ? gene expression may explain the reduced levels of IFN ? in TB patients. Objective: To investigate the relationships of genetic variants in the transcription factors TBET, STAT1, STAT4, and HLX to susceptibility/resistance to pulmonary TB. Materials and methods: Eight candidate single-nucleotide polymorphisms (SNPs) were selected, and genotyped in 466 unrelated pulmonary TB patients and 300 healthy controls from Colombia, and the allelic and genetic associations with TB were analyzed. Results: The results indicate that no SNP in the transcription factors studied is associated with TB. However, polymorphism rs11650354 in the TBET gene may be associated with a decreased risk of TB; the TT genotype was significantly associated with TB protection in a recessive genetic model (OR=0.089, 95% CI: 0.01-0.73, p=0.0069), although this association was not maintained after multiple test correction (EMP2= 0.61). Conclusion: In this study, the rs11650354 variant of TBET was suggested to promote resistance to TB in a Colombian population. A future replication case-control study using additional samples will be necessary to confirm this suggestive association.

Introducción. El interferón gama (IFN ? ) es la citocina más potente para controlar la infección por Mycobacterium tuberculosis , el agente etiológico de la tuberculosis humana. Los pacientes con tuberculosis activa presentan reducción de los niveles de IFN ? , lo cual parece explicar la inmunidad poco efectiva contra el bacilo. La disminución de su expresión o alteraciones funcionales de los factores transactivadores del promotor del gen de IFN ? , podrían explicar la reducción de los niveles de IFN ? en los pacientes con tuberculosis. Objetivo. Determinar la asociación de variantes genéticas en los factores de transcripción TBET STAT1, STAT4 y HLX con sensibilidad o resistencia a tuberculosis pulmonar. Materiales y métodos. Se seleccionaron ocho polimorfismos de un solo nucleótido ( Single-Nucleotide Polymorphism , SNP) y se estableció su genotipo, en 466 pacientes con tuberculosis pulmonar y 300 controles sanos en Colombia; además, se hizo un análisis de asociación alélica y genética. Resultados. Los resultados indican que los SNP de los factores de transcripción estudiados no están asociados con tuberculosis; sin embargo, el polimorfismo rs11650354 en TBET puede estar implicado en la disminución de riesgo de tuberculosis. El genotipo TT de TBET se asoció significativamente con protección contra tuberculosis usando un modelo genético recesivo (OR=0,089; CI 95% : 0,01-0,73; p=0,0069); sin embargo, la corrección mediante pruebas múltiples de ajuste abolió esta asociación ( Empirical P Value, EMP2=0,61). Conclusión. En este estudio se sugiere un efecto de la variante rs11650354 de TBET sobre la resistencia a la tuberculosis en la población colombiana. Es necesario desarrollar un estudio de replicación usando muestras adicionales para confirmar esta asociación sugestiva.
Descritores: Interferon gama/genética
Tuberculose Pulmonar/genética
-Estudos de Casos e Controles
Colômbia
Regulação da Expressão Gênica
Predisposição Genética para Doença
Proteínas de Homeodomínio/genética
Polimorfismo de Nucleotídeo Único
Fatores de Risco
Fator de Transcrição STAT1/genética
/genética
STATABBREVIATIONS AS TOPIC TRANSCRIPTION FACTOR/genética
Proteínas com Domínio T/genética
Fatores de Transcrição/genética
Limites: Adulto
Feminino
Humanos
Masculino
Pessoa de Meia-Idade
Tipo de Publ: Research Support, Non-U.S. Gov't
Responsável: CO332 - Facultad de Medicina


  4 / 4 LILACS  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
Texto completo
Id: lil-676940
Autor: Araujo, Ricardo V.; Chang, Claudia V.; Cescato, Valter A. S.; Fragoso, Maria Candida B. V.; Bronstein, Marcello D.; Mendonca, Berenice B.; Arnhold, Ivo J. P.; Carvalho, Luciani R. S..
Título: PROP1 overexpression in corticotrophinomas: evidence for the role of PROP1 in the maintenance of cells committed to corticotrophic differentiation
Fonte: Clinics;68(6):887-891, jun. 2013. tab, graf.
Idioma: en.
Resumo: OBJECTIVE: The expression of transcription factors involved in early pituitary development, such as PROP1 and POU1F1, has been detected in pituitary adenoma tissues. In this study, we sought to characterize the transcriptional profiles of PROP1, POU1F1, and TBX19 in functioning and nonfunctioning pituitary adenomas in an attempt to identify their roles in tumorigenesis and hormone hypersecretion. METHODS: RT-qPCR analyses were performed to assess the transcriptional pattern of PROP1, POU1F1, TBX19, and hormone-producing genes in tissue samples of corticotrophinomas (n = 10), somatotrophinomas (n = 8), and nonfunctioning adenomas (n = 6). RESULTS: Compared with normal pituitary tissue, POU1F1 was overexpressed in somatotrophinomas by 3-fold. PROP1 expression was 18-fold higher in corticotrophinomas, 10-fold higher in somatotrophinomas, and 3-fold higher in nonfunctioning adenomas. TBX19 expression was 27-fold higher in corticotrophinomas. Additionally, the level of TBX19 mRNA positively correlated with that of pro-opiomelanocortin (r = 0.49, p = 0.014). CONCLUSIONS: Our data demonstrate that PROP1 is overexpressed in pituitary adenomas, mainly in corticotrophinomas. Together with previously published data showing that patients who harbor PROP1 loss-of-function mutations present a progressive decline in corticotrope function, our results support a role for PROP1 in pituitary tumor development and in the maintenance of cell lineages committed to corticotrophic differentiation. .
Descritores: Adenoma Hipofisário Secretor de ACT/metabolismo
Adenoma/metabolismo
Proteínas de Homeodomínio/metabolismo
Proteínas de Neoplasias/metabolismo
Proteínas com Domínio T/metabolismo
Fator de Transcrição Pit-1/metabolismo
-Adenoma Hipofisário Secretor de ACT/genética
Adenoma Hipofisário Secretor de ACT/patologia
Adenoma/genética
Adenoma/patologia
Diferenciação Celular
Proteínas de Homeodomínio/genética
Imuno-Histoquímica
Proteínas de Neoplasias/genética
Hipófise
Reação em Cadeia da Polimerase em Tempo Real
RNA Mensageiro/metabolismo
Proteínas com Domínio T/genética
Fator de Transcrição Pit-1/genética
Fatores de Transcrição/genética
Fatores de Transcrição/metabolismo
Limites: Adolescente
Adulto
Idoso
Feminino
Humanos
Masculino
Pessoa de Meia-Idade
Adulto Jovem
Tipo de Publ: Research Support, Non-U.S. Gov't
Responsável: BR1.1 - BIREME



página 1 de 1
   


Refinar a pesquisa
  Base de dados : Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde